issuance of new debentures. Meanwhile, interest expense on deposits increased by 7.5% from the increased in deposit amount by 20.9% yoy consistent with the growth in overall loan portfolio. The cost of fund
-on-period basis was attributable to the Company having some costs in personnel, doctor fee, drugs and medical supplies, depreciation, electricity charge, medical utensils costs, and medical consumable
1.7% QoQ as the cost of utility started to decrease offset by increased NT’s partnership cost and maintenance costs. • Regulatory fee was at Bt1,369mn, a decrease of -0.4% YoY and -1.8% QoQ. The
3Q22, the cost of service was at Bt21,863mn, increased 2.0% YoY and 1.1% QoQ mainly from the increase in network OPEX due to rising of utility cost. • Regulatory fee was at Bt1,380mn, increased 1.9% YoY
enterprise customers. The revenue softened -6.9% QoQ from the large project sales during 4Q22. EBITDA rebounded YoY from growth in core businesses and cost optimization discipline 1Q23 recorded an EBITDA of
optimization. Cost & Expense 1Q24, the cost of service was Bt24,881mn, increasing 13% YoY and 8.0% QoQ from consolidating full quarter of TTTBB’s cost. • Regulatory fee was Bt1,581mn, increasing 13% YoY and 4.8
services to uplift the ARPU. Sustaining growth in the bottom line with profitable revenue focus and cost discipline. 3Q23 provided an EBITDA of Bt23,674mn, increasing 7.2% YoY and 1.5% QoQ with a healthy
Bt1,588mn, improving 30% YoY and 6.9% QoQ driven by robust demand for Cloud service and ICT solutions. Cost & Expense In 2Q22, the cost of service was Bt21,630mn, increasing 2.9% YoY and 0.4% QoQ mainly from